demonstrated that in GBM CSCs, VEGF inhibits cell invasiveness by blocking HGF receptor (Met)/VEGFR2 interaction and recruiting PTP1B phosphatase, which promotes Met dephosphorylation. This evidence concerns the gene MET and glioblastoma.